echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Fujian Province comprehensively promotes 4 + 7 centralized purchase: give priority to the use of selected drugs, directly hang on the Internet, and do not need to have a pharmaceutical meeting

    Fujian Province comprehensively promotes 4 + 7 centralized purchase: give priority to the use of selected drugs, directly hang on the Internet, and do not need to have a pharmaceutical meeting

    • Last Update: 2019-05-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On May 21, Fujian health and Health Commission issued the notice to follow up and implement the centralized purchase of selected drugs organized by the state We will comprehensively promote drug 4 + 7 centralized purchase, and the notice clearly points out that public medical institutions shall not affect the rational use of selected drugs on the grounds of cost control, drug proportion and requirements for drug varieties, specifications and quantities of medical institutions All public medical institutions should optimize the drug use structure, timely include the selected drugs into the drug prescription set and the basic drug supply catalog The selected drugs can be purchased directly on the provincial platform without the approval of the hospital pharmacy management and pharmacotherapy Committee The following is the original notice: each district and City Health Committee, Pingtan comprehensive experimental district health and Family Planning Bureau, provincial health and Health Committee affiliated medical units, Fujian Medical University, affiliated hospitals of the University of traditional Chinese medicine: In order to implement the notice of the general office of the national health and Health Commission on doing well in the clinical allocation and use of selected drugs in the centralized purchase of drugs organized by the state (Guo Wei ban Yi Han [2019] No 77) and the notice of the general office of the people's Government of Fujian Province on printing and distributing the implementation plan for the comprehensive implementation and follow-up of the pilot work of centralized purchase and use of drugs organized by the state (min Zheng ban [2019] No 31) (1) the Party Central Committee and the State Council attach great importance to the allocation and use of the selected drugs We hereby notify the following requirements: 1 Attach great importance to the allocation and use of the selected drugs 2 The national organization of drug centralized purchase and use pilot is an important measure to implement the State Council's requirements of "ensuring the public to use high-quality and cheap drugs", which is a major reform of the previous drug centralized purchase system, as well as a concrete embodiment of the deepening development of China's medical reform The provincial administrative departments of health and health at all levels should firmly establish the "Four Consciousness", attach great importance to the clinical allocation and use of selected drugs, strengthen guidance and scheduling, and steadily promote the pilot All public medical institutions in the province should fully understand the significance of the national organization of drug centralized procurement and use pilot, strengthen policy learning, earnestly fulfill their responsibilities, equip and reasonably use the selected drugs, practically guarantee the dosage, and further reduce the burden of drug costs on the masses 2、 The provincial health and Health Commission, together with the provincial health insurance bureau, will decompose the basic purchase amount of selected drugs to the provincial public medical institutions and cities, and the administrative departments of health and health at all levels, together with the medical insurance departments, will decompose and implement it to the public medical institutions, and organize the public medical institutions, the selected production enterprises and the distribution enterprises determined by them according to the selected price Three party sales and purchase contract with quantity shall be signed to ensure the agreed purchase quantity within one year The administrative departments of health and health at all levels shall strengthen the guidance and supervision over the use of selected drugs in public medical institutions, and guide public medical institutions to give priority to the purchase and use of selected drugs in accordance with the agreed purchase volume All public medical institutions shall not influence the rational use of the selected drugs on the grounds of cost control, drug proportion and requirements for drug varieties, specifications and quantities of medical institutions All public medical institutions should optimize the drug use structure, timely include the selected drugs into the drug prescription set and the basic drug supply catalog The selected drugs can be purchased directly on the provincial platform without the approval of the hospital pharmacy management and pharmacotherapy Committee 3、 Strengthen publicity and training for medical staff and patients The administrative departments of health and health at all levels, together with the departments of medical insurance and drug supervision, shall guide the public medical institutions within their jurisdiction to actively carry out publicity and training for medical personnel and hold special lectures on the consistency evaluation of generic drugs, so that medical personnel can understand the significance of the national policy of centralized purchase and use of drugs, master the basic principles and precautions for the rational use of drugs, and improve the level of rational use 。 All public medical institutions should do a good job in clinical risk assessment, plan formulation, drug use monitoring and emergency response, guide medical staff to actively respond to patients' concerns and explain patients 4、 Improve the rational use level of selected drugs All medical institutions in the province shall strictly implement the prescription management measures, the regulations on the administration of pharmaceutical affairs in medical institutions, the regulations on the administration of prescription reviews in hospitals (Trial), the regulations on the examination of prescriptions in medical institutions, and the relevant diagnosis and treatment specifications and medication guidelines, and strictly implement the requirements for prescribing according to the common name of drugs, so as to ensure that the drugs selected in use are given priority under the same conditions We should give full play to the role of clinical pharmacists, strengthen the examination and evaluation of prescriptions, and ensure the safety of patients' medication 5、 Establish and improve relevant incentive mechanism and performance appraisal system The health administration departments at all levels shall include the public medical institutions in the performance appraisal system of public hospitals and the comprehensive incentive appraisal system of public primary medical institutions, such as purchasing and using the selected drugs and properly responding to the concerns of patients The appraisal results shall be linked with the annual salary of the president of public hospitals, the total salary, the unit evaluation and the talent evaluation The head of each medical institution shall take the leadership responsibility for the purchase and use of the selected drugs in the institution, properly respond to the concerns of patients, establish incentive mechanism and preferential measures to encourage the use of the selected drugs, and incorporate them into the performance assessment of clinical departments and physicians 6、 Monitor the purchase and use of selected drugs Establish a regular monitoring system for the use of selected drugs The national short drug direct reporting system will open a monitoring function module for the use of selected drugs (hereinafter referred to as "direct reporting system") All public medical institutions in the province shall regularly monitor and analyze the purchase and use of selected drugs in their own institutions, and log in to the direct reporting system to fill in the monitoring data before the 3rd day of each month The administrative departments of health and health at all levels shall timely grasp the work progress of medical institutions within their jurisdiction, give early warning of possible or potential problems, and conduct on-site supervision and inspection when necessary to ensure the smooth implementation of the pilot work Fujian Provincial Health Committee may 20, 2019
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.